Literature DB >> 1412575

Hematogenous factors and prediction of delayed ischemic deficit after subarachnoid hemorrhage.

S F Ameriso1, V L Wong, H Ishii, F P Quismorio, S L Giannotta, H J Meiselman, M Fisher.   

Abstract

BACKGROUND AND
PURPOSE: Delayed ischemic deficits contribute to the high morbidity and mortality rates associated with subarachnoid hemorrhage. We evaluated the potential usefulness of measuring coagulation and hemorheological variables and cardiolipin antibodies for prediction of delayed ischemic deficit after subarachnoid hemorrhage.
METHODS: Consecutive patients with subarachnoid hemorrhage were studied. Coagulation and hemorheological variables and cardiolipin antibodies were measured on admission, within 7 days of subarachnoid hemorrhage. A subset of patients was studied on admission and at two subsequent occasions.
RESULTS: Sixty-nine patients were studied. Sixty-one of these were without clinical manifestations of vasospasm at admission, and 16 developed delayed ischemic deficit during their hospitalization. None of the laboratory variables measured were significantly different between patients with or without later development of delayed ischemic deficit. Elevation of the fibrin fragment D-dimer was found in the group of eight patients admitted with ischemic symptoms and in 49% (34 of 69) of all patients, but this was not associated with delayed ischemic deficit. Sixteen patients were studied on three occasions; this group showed a significant decrease in hematocrit, an increased white blood cell count, and no change in fibrinogen concentration. Fibrin D-dimer levels rose significantly after surgery (from 5.01 +/- 0.69 to 5.53 +/- 0.58 ln-ng/ml, p less than 0.025) and after onset of delayed ischemic deficit (from 4.71 +/- 0.64 to 5.84 +/- 0.34 ln-ng/ml, p less than 0.01).
CONCLUSIONS: Hemostatic measurements, hemorheological variables, and cardiolipin immunoreactivity did not predict delayed ischemic deficit in this population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1412575     DOI: 10.1161/01.str.23.10.1404

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Anti-phospholipid antibodies and cerebral vasospasm following subarachnoid haemorrhage.

Authors:  Y Hirashima; M Kurimoto; E Tsukamoto; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review.

Authors:  Jacoline Boluijt; Joost C M Meijers; Gabriel J E Rinkel; Mervyn D I Vergouwen
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-18       Impact factor: 6.200

Review 3.  Appraising the use of tranexamic acid in traumatic and non-traumatic intracranial hemorrhage: A narrative review.

Authors:  Nicholas D Jakowenko; Brian J Kopp; Brian L Erstad
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-07-15

4.  Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.

Authors:  Y Hirashima; S Endo; M Kurimoto; E Tsukamoto; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Prognostic significance of combined score of fibrinogen and neutrophil-lymphocyte ratio for functional outcome in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Yuyang Hou; Hua Li; Hongkuan Yang; Rudong Chen; Jiasheng Yu
Journal:  Front Neurol       Date:  2022-08-16       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.